U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C21H18N4OS
Molecular Weight 374.459
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PF-3644022

SMILES

C[C@@H]1CNC2=C(SC3=CC=C4N=C(C=CC4=C23)C5=CN=C(C)C=C5)C(=O)N1

InChI

InChIKey=CMWRPDHVGMHLSZ-GFCCVEGCSA-N
InChI=1S/C21H18N4OS/c1-11-3-4-13(10-22-11)15-6-5-14-16(25-15)7-8-17-18(14)19-20(27-17)21(26)24-12(2)9-23-19/h3-8,10,12,23H,9H2,1-2H3,(H,24,26)/t12-/m1/s1

HIDE SMILES / InChI

Molecular Formula C21H18N4OS
Molecular Weight 374.459
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Description
Curator's Comment: description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/24601623 | http://google.com/patents/WO2015173788A1 | https://www.ncbi.nlm.nih.gov/pubmed/22746295

PF 3644022 is potent, ATP-competitive inhibitor of mitogen-activated protein kinase (MAPK)-activated protein kinase-2 (MK2) (IC50 = 5.2 nM; Ki = 3 nM). Inhibits tumor necrosis factor α (TNFα) production in U937 monocytic cells and peripheral blood mononuclear cells (PBMCs) (IC50 = 160 nM). PF-3644022 is orally efficacious at inhibiting TNFalpha production in LPS-challenged rats and blocking paw swelling in the chronic SCW-arthritis model.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
5.0 nM [IC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
A benzothiophene inhibitor of mitogen-activated protein kinase-activated protein kinase 2 inhibits tumor necrosis factor alpha production and has oral anti-inflammatory efficacy in acute and chronic models of inflammation.
2010-06
Patents

Patents

Sample Use Guides

Arthritis was induced in 125- to 140-g female Lewis rats (Harlan) by a single intraperitoneal injection of peptidoglycan–polysaccharide complexes from group A SCW purchased from Lee Laboratories (Grayson, GA). The disease course was biphasic with an acute inflammatory non-T cell-dependent phase on days 1 to 3 followed by a chronic T cell-ependent inflammatory-erosive arthritis developing over days 14 to 28. Animals developing the acute inflammatory phase were pooled into groups of seven to eight animals per group and dosed with PF-3644022 or methylcellulose-Tween 20 vehicle by oral gavage (1 ml) twice a day for days 10 to 21. Hind paw swelling volumes were measured on day 21 with a displacement plethysmometer
Route of Administration: Oral
PF-3644022 was added to human whole blood (HWB) ex vivo 1 h before stimulation with 100 ng/ml LPS at 37°C. TNFalpha was measured 4 h poststimulation by assaying plasma with a human TNFalpha MSD kit. TNFalpha, IL-1, IL-6, and IL-8 in plasma was also measured after 16-h LPS stimulation of HWB by using a four-plex human cytokine MSD plate
Substance Class Chemical
Created
by admin
on Wed Apr 02 05:44:52 GMT 2025
Edited
by admin
on Wed Apr 02 05:44:52 GMT 2025
Record UNII
N4H5CH3E5S
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
PF-3644022
Code English
PF-364402
Preferred Name English
(R)-10-Methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one
Systematic Name English
8H-[1,4]Diazepino[5?,6?:4,5]thieno[3,2-f]quinolin-8-one, 9,10,11,12-tetrahydro-10-methyl-3-(6-methyl-3-pyridinyl)-, (10R)-
Systematic Name English
(10R)-9,10,11,12-Tetrahydro-10-methyl-3-(6-methyl-3-pyridinyl)-8H-[1,4]diazepino[5?,6?:4,5]thieno[3,2-f]quinolin-8-one
Systematic Name English
Code System Code Type Description
CAS
1276121-88-0
Created by admin on Wed Apr 02 05:44:52 GMT 2025 , Edited by admin on Wed Apr 02 05:44:52 GMT 2025
PRIMARY
PUBCHEM
44631903
Created by admin on Wed Apr 02 05:44:52 GMT 2025 , Edited by admin on Wed Apr 02 05:44:52 GMT 2025
PRIMARY
FDA UNII
N4H5CH3E5S
Created by admin on Wed Apr 02 05:44:52 GMT 2025 , Edited by admin on Wed Apr 02 05:44:52 GMT 2025
PRIMARY
EPA CompTox
DTXSID901352019
Created by admin on Wed Apr 02 05:44:52 GMT 2025 , Edited by admin on Wed Apr 02 05:44:52 GMT 2025
PRIMARY